Immunotherapy and PD-L1: A primer
Advances in precision medicine have led to a shift in paradigm for oncology research, from targeted therapies that rely largely on tyrosine kinase inhibitors (TKIs) to personalized therapy that can...
Fighting cancer takes precision
On February 4, we commemorated World Cancer Day, a day when researchers, physicians, patients and other interested groups acknowledge all the hard work being done to fight this global disease. This...
Immunotherapy takes center stage on World Cancer Day
Author: Kathleen Gray, PhDThis is an exciting time to be working in the field of cancer research. Throughout the last few years, amazing strides have been made toward the ultimate goal: to turn...
Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options by Victor Weigman
Authors: Victor Weigman, Ph.D. & Patrice Hugo, Ph.D.With advancements in clinical informatics and genomics, there has been a paradigm shift from “one drug fits all” toward precision medicine – taking...
Setting Up for Success
Until recently most flow cytometers were routinely characterized and calibrated using beads that contained surrogate dyes, with standardized quantitative measurements restricted to those few...
Better Together
Earlier this year, Quintiles and Quest Diagnostics launched Q2 Solutions, a combined clinical trials laboratory services organization. This isn’t just important for the companies involved. It...
